Published in Infect Immun on July 01, 1988
Clostridium difficile: clinical disease and diagnosis. Clin Microbiol Rev (1993) 2.19
pH-induced conformational changes in Clostridium difficile toxin B. Infect Immun (2000) 1.75
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
Effects of Clostridium difficile toxin B on human monocytes and macrophages: possible relationship with cytoskeletal rearrangement. Infect Immun (1993) 0.90
Primary human colonic myofibroblasts are resistant to Clostridium difficile toxin A-induced, but not toxin B-induced, cell death. Infect Immun (2011) 0.83
Harnessing the glucosyltransferase activities of Clostridium difficile for functional studies of toxins A and B. J Clin Microbiol (2011) 0.82
Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays. J Clin Microbiol (1992) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Purification and characterization of toxins A and B of Clostridium difficile. Infect Immun (1982) 6.88
Effects of Clostridium difficile toxins given intragastrically to animals. Infect Immun (1985) 5.44
Comparison of two toxins produced by Clostridium difficile. Infect Immun (1981) 5.16
Studies on the chemical structure of the streptococcal cell wall. II. The composition of group C cell walls and chemical basis for serologic specificity of the carbohydrate moiety. J Exp Med (1962) 5.00
Purification and characterization of Clostridium difficile toxin. Infect Immun (1979) 2.71
Partial purification and characterization of a cytotoxin from Clostridium difficile. Rev Infect Dis (1980) 2.31
Biochemical characterization and biologic actions of two toxins (D-1 and D-2) from Clostridium difficile. Rev Infect Dis (1984) 2.26
Purification and properties of Clostridium difficile cytotoxin B. J Biol Chem (1986) 1.97
Purification and partial characterization of a putative precursor to staphylococcal enterotoxin B. Infect Immun (1981) 1.64
Biochemical studies on the effect of Clostridium difficile toxin B on actin in vivo and in vitro. Infect Immun (1987) 1.34
Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell (1997) 3.17
Identification of a membrane-spanning domain of the thiol-activated pore-forming toxin Clostridium perfringens perfringolysin O: an alpha-helical to beta-sheet transition identified by fluorescence spectroscopy. Biochemistry (1998) 2.98
The mechanism of membrane insertion for a cholesterol-dependent cytolysin: a novel paradigm for pore-forming toxins. Cell (1999) 2.89
The mechanism of pore assembly for a cholesterol-dependent cytolysin: formation of a large prepore complex precedes the insertion of the transmembrane beta-hairpins. Biochemistry (2000) 1.95
Capacity of listeriolysin O, streptolysin O, and perfringolysin O to mediate growth of Bacillus subtilis within mammalian cells. Infect Immun (1992) 1.91
Mechanism of membrane insertion of a multimeric beta-barrel protein: perfringolysin O creates a pore using ordered and coupled conformational changes. Mol Cell (2000) 1.87
Diphtheria toxin. Effect of substituting aspartic acid for glutamic acid 148 on ADP-ribosyltransferase activity. J Biol Chem (1985) 1.70
Transport and processing of staphylococcal enterotoxin B. J Bacteriol (1983) 1.68
Purification and partial characterization of a putative precursor to staphylococcal enterotoxin B. Infect Immun (1981) 1.64
Arresting pore formation of a cholesterol-dependent cytolysin by disulfide trapping synchronizes the insertion of the transmembrane beta-sheet from a prepore intermediate. J Biol Chem (2000) 1.64
Beta-barrel pore-forming toxins: intriguing dimorphic proteins. Biochemistry (2001) 1.60
Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. J Infect Dis (1997) 1.52
Clostridium septicum alpha toxin uses glycosylphosphatidylinositol-anchored protein receptors. J Biol Chem (1999) 1.26
Molecular cloning and expression of gene fragments from corynebacteriophage beta encoding enzymatically active peptides of diphtheria toxin. J Bacteriol (1983) 1.24
Activation and mechanism of Clostridium septicum alpha toxin. Mol Microbiol (1993) 1.24
The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae. J Mol Biol (1998) 1.20
Generation of a membrane-bound, oligomerized pre-pore complex is necessary for pore formation by Clostridium septicum alpha toxin. Mol Microbiol (1997) 1.19
Kinetic aspects of the aggregation of Clostridium perfringens theta-toxin on erythrocyte membranes. A fluorescence energy transfer study. J Biol Chem (1991) 1.16
Self-interaction of pneumolysin, the pore-forming protein toxin of Streptococcus pneumoniae. J Mol Biol (1998) 1.16
Transport and processing of staphylococcal alpha-toxin. J Bacteriol (1983) 1.15
The primary structure of Clostridium septicum alpha-toxin exhibits similarity with that of Aeromonas hydrophila aerolysin. Infect Immun (1995) 1.12
Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. FEMS Immunol Med Microbiol (1993) 1.11
Purification and characterization of the lethal toxin (alpha-toxin) of Clostridium septicum. Infect Immun (1992) 1.06
Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect Immun (2000) 1.05
Clostridium septicum alpha-toxin is proteolytically activated by furin. Infect Immun (1997) 1.04
The propeptide of Clostridium septicum alpha toxin functions as an intramolecular chaperone and is a potent inhibitor of alpha toxin-dependent cytolysis. Mol Microbiol (1997) 0.99
Clinical courses of seven survivors of Clostridium septicum infection and their immunologic responses to alpha toxin. Clin Infect Dis (1994) 0.93
Evidence that Clostridium perfringens theta-toxin induces colloid-osmotic lysis of erythrocytes. Infect Immun (1991) 0.91
Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters. J Infect Dis (1995) 0.91
Expression and properties of an aerolysin--Clostridium septicum alpha toxin hybrid protein. Mol Microbiol (1999) 0.88
Crystallization and preliminary X-ray analysis of a thiol-activated cytolysin. FEBS Lett (1996) 0.87
Ionic interactions between proteins in nonequilibrium pH gradient electrophoresis: histones affect the migration of high mobility group nonhistone chromatin proteins. Anal Biochem (1983) 0.81
Purification of staphylococcal enterotoxins. Methods Enzymol (1988) 0.79
Efficient gene delivery and expression in mammalian cells using DNA coupled with perfringolysin O. Gene Ther (1995) 0.76
Transport and processing of staphylococcal enterotoxin A. Appl Environ Microbiol (1985) 0.75